Ligand validation:4K0A

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4K0A designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4K0A_NAG_A_505	72%	89%	0.11	0.935	0.19	0.44	-	-	0	0	100%	0.9333
4K0A_NAG_A_504	71%	89%	0.115	0.934	0.24	0.39	-	-	0	0	100%	0.9333
4K0A_NAG_A_501	68%	86%	0.145	0.958	0.18	0.52	-	-	0	0	100%	0.9333
4K0A_NAG_A_507	53%	90%	0.132	0.891	0.29	0.33	-	-	0	0	100%	0.9333
4K0A_NAG_A_502	43%	85%	0.196	0.921	0.26	0.47	-	-	0	0	100%	0.9333
4K0A_NAG_A_506	36%	87%	0.217	0.912	0.33	0.36	-	-	0	0	100%	0.9333
4K0A_NAG_A_508	23%	88%	0.25	0.876	0.23	0.44	-	-	0	0	100%	0.9333
4K0A_NAG_A_503	7%	89%	0.295	0.755	0.2	0.42	-	-	0	0	100%	0.9333
4JZW_NAG_A_502	96%	76%	0.063	0.973	0.52	0.42	-	-	0	0	100%	0.9333
4KA2_NAG_A_504	86%	66%	0.083	0.95	0.65	0.66	-	-	1	0	100%	0.9333
4LAJ_NAG_B_507	81%	78%	0.106	0.959	0.48	0.41	-	-	0	0	100%	0.9333
4JZZ_NAG_A_504	81%	74%	0.093	0.944	0.29	0.71	-	-	0	0	100%	0.9333
4DVR_NAG_G_502	68%	69%	0.137	0.948	0.53	0.68	-	-	1	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.